Our group has also demonstrated that the replication potency of XVir-N-31 is sufficient to induce in combination with cyclin dependent kinases 4/6 inhibitor (CDK4/6i) abscopal anti-tumor effects in a humanized mouse model32. The gene discussed is CDK4; the disease is neoplasm.